Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 41Ovarian Neoplasms 4Neoplasms 4Neoplasm Metastasis 4Squamous Cell Carcinoma of Head and Neck 3Lymphoma 3Breast Diseases 3Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neuroblastoma 2Neoplasms by Site 2Medulloblastoma 2Lymphoma, Mantle-Cell 2Liposarcoma 2Hematologic Neoplasms 2Glioma 2Carcinoma, Renal Cell 2Breast Neoplasm Female 2Xanthogranuloma, Juvenile 1Wilms Tumor 1Venous Thromboembolism 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unilateral Breast Neoplasms 1Thyroid Neoplasms 1

Interventions

Carboplatin 2palbociclib 1Vorinostat 1Trastuzumab 1Taxes 1Tamoxifen 1Radiotherapy 1Paclitaxel 1Letrozole 1Fulvestrant 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Anastrozole 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Lobular × palbociclib × Clear all
NCT02764541 2025-05-07

Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)

Dana-Farber Cancer Institute

Phase 2 Active not recruiting
195 enrolled 26 charts
Breast

Breast Neoplasms, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡